Advertisement
News
Advertisement

Alnylam announces positive results of cancer vaccine

Wed, 08/22/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY) announced the results of pre-clinical studies today using its RNA interference (RNAi) technology which it says could lead to the development of more effective vaccine therapies for cancer as well as infectious diseases.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading